{"bill":{"bill_id":1275127,"change_hash":"2fe25a91041ffa1ae2df0764440fd1d6","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/HB4400\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/4400\/all-info","completed":0,"status":1,"status_date":"2019-09-19","progress":[{"date":"2019-09-19","event":1},{"date":"2019-09-19","event":9},{"date":"2019-09-19","event":9},{"date":"2019-09-19","event":9},{"date":"2019-09-20","event":9}],"state":"US","state_id":52,"bill_number":"HB4400","bill_type":"B","bill_type_id":"1","body":"H","body_id":114,"current_body":"H","current_body_id":114,"title":"Advancing Education on Biosimilars Act of 2019","description":"Requires the Department of Health and Human Services (HHS) to maintain a website and undertake other activities to educate health care providers, patients, and caregivers about biological products, biosimilar biological products, and interchangeable biosimilar biological products. Among other activities, HHS must develop or improve continuing education programs that address clinical considerations for biological and related products. Health care providers eligible for the Merit-based Incentive Payment System in Medicare may count completion of such a program as a clinical practice improvement activity.","pending_committee_id":2355,"committee":{"committee_id":2355,"chamber":"H","chamber_id":114,"name":"Subcommittee on Health"},"referrals":[{"date":"2019-09-19","committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"},{"date":"2019-09-20","committee_id":2355,"chamber":"H","chamber_id":114,"name":"Subcommittee on Health"}],"history":[{"date":"2019-09-19","action":"Introduced in House","chamber":"H","chamber_id":114,"importance":0},{"date":"2019-09-19","action":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.","chamber":"H","chamber_id":114,"importance":1},{"date":"2019-09-19","action":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.","chamber":"H","chamber_id":114,"importance":1},{"date":"2019-09-19","action":"Referred to the Subcommittee on Health.","chamber":"H","chamber_id":114,"importance":1},{"date":"2019-09-20","action":"Referred to the Subcommittee on Health.","chamber":"H","chamber_id":114,"importance":1}],"sponsors":[{"people_id":11042,"person_hash":"q6aavo7l","party_id":"2","state_id":52,"party":"R","role_id":1,"role":"Rep","name":"Larry Bucshon","first_name":"Larry","middle_name":"","last_name":"Bucshon","suffix":"","nickname":"","district":"HD-IN-8","ftm_eid":7004017,"votesmart_id":120335,"opensecrets_id":"N00031227","knowwho_pid":284631,"ballotpedia":"Larry_Bucshon","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":8970,"person_hash":"7kmcyqxq","party_id":"1","state_id":52,"party":"D","role_id":1,"role":"Rep","name":"Eliot Engel","first_name":"Eliot","middle_name":"L.","last_name":"Engel","suffix":"","nickname":"","district":"HD-NY-16","ftm_eid":17658812,"votesmart_id":26972,"opensecrets_id":"N00001003","knowwho_pid":158986,"ballotpedia":"Eliot_Engel","sponsor_type_id":2,"sponsor_order":2,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":8,"type":"Related","sast_bill_number":"SB1895","sast_bill_id":1269526},{"type_id":8,"type":"Related","sast_bill_number":"HB19","sast_bill_id":1287821},{"type_id":8,"type":"Related","sast_bill_number":"SB4796","sast_bill_id":1379878},{"type_id":8,"type":"Related","sast_bill_number":"HB8527","sast_bill_id":1379757}],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13593,"subject_name":"Drug safety, medical device, and laboratory regulation"},{"subject_id":13200,"subject_name":"Government information and archives"},{"subject_id":13211,"subject_name":"Health personnel"},{"subject_id":13212,"subject_name":"Health programs administration and funding"},{"subject_id":81056,"subject_name":"Immunology and vaccination"},{"subject_id":13312,"subject_name":"Licensing and registrations"},{"subject_id":13240,"subject_name":"Medical education"},{"subject_id":13242,"subject_name":"Medicare"},{"subject_id":13490,"subject_name":"Prescription drugs"}],"texts":[{"doc_id":2054667,"date":"2019-09-25","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/HB4400\/id\/2054667","state_link":"https:\/\/www.congress.gov\/116\/bills\/hr4400\/BILLS-116hr4400ih.pdf","text_size":352645,"text_hash":"b47d50df869e8fac7b7af5fb96b82c7a"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}